Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
LANNETT COMPANY, INC. v. CELGENE CORPORATION
Case Number:
2:08-cv-03920
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
December 07, 2011
Lannett Cuts Deal With Celgene In Thalomid Antitrust Case
Lannett Co. Inc. on Tuesday resolved its antitrust suit in Pennsylvania federal court alleging Celgene Corp. unfairly blocked it from launching a generic version of Celgene's thalidomide-based cancer drug Thalomid.
-
March 31, 2011
Judge Nixes Dismissal Bid In Thalomid Antitrust Suit
A federal judge in Pennsylvania on Thursday denied a second attempt by Celgene Corp. to dismiss an antitrust complaint by a generics maker that wants to market a version of the company's thalidomide-based cancer drug Thalomid.
-
March 29, 2011
Lannett Loses Bid To Enforce Celgene Oral Agreement
A Pennsylvania federal judge on Tuesday shot down Lannett Co. Inc.'s attempt to enforce what it claimed was an oral agreement with Celgene Corp. to settle an antitrust suit over cancer drug Thalomid.